- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/11 - Orthomyxoviridae, p. ex. virus de l'influenza
Détention brevets de la classe C07K 14/11
Brevets de cette classe: 618
Historique des publications depuis 10 ans
|
23
|
38
|
42
|
39
|
34
|
36
|
43
|
41
|
23
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Icahn School of Medicine at Mount Sinai | 1032 |
18 |
| Medicago Inc. | 127 |
18 |
| Sanofi Pasteur Inc. | 287 |
17 |
| Aramis Biotechnologies Inc. | 57 |
17 |
| Janssen Vaccines & Prevention B.V. | 272 |
14 |
| FluGen, Inc. | 38 |
12 |
| Intervet International B.V. | 1340 |
11 |
| Longhorn Vaccines and Diagnostics, LLC | 93 |
11 |
| Intervet Inc. | 927 |
10 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
10 |
| Duke University | 3183 |
8 |
| AVIR Green Hills Biotechnology Research Development Trade AG | 10 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
6 |
| Seqirus Inc. | 262 |
6 |
| The Regents of the University of California | 20745 |
4 |
| Massachusetts Institute of Technology | 10251 |
4 |
| Purdue Research Foundation | 3916 |
4 |
| Academia Sinica | 958 |
4 |
| Folia Biotech Inc. | 10 |
4 |
| Georgia State University Research Foundation, Inc. | 357 |
4 |
| Autres propriétaires | 430 |